Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis
Status:
Suspended
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomised, double-blind, placebo-controlled, phase II study is to assess
the efficacy and safety of orally administered DS102 in patients with acute decompensated
alcoholic hepatitis